Tailstorm Health INC recalls KETAmine Hydrochloride Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
- Products
-
- KETAmine Hydrochloride Injection
- Company
- Tailstorm Health INC
- Where it was sold
-
Nationwide in the US
Nationwide
- Units affected
- 23,200 vials
- About this recall
- KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0.